About webmaster-prism

This author has not yet filled in any details.
So far webmaster-prism has created 104 blog entries.

Why Order Sets are a Key Part of the Prescriber Journey

2022-04-26T20:03:47+00:00April 26th, 2022|Categories: Blog|

  In its simplest form, an order set is like a decision tree for healthcare providers. At the top of the tree are the diagnostics and tests, and based on the results and disease state, physicians can follow specific branches of treatment that best match the patient’s needs, including scans, care procedures, and drugs.  Order sets are created based on consensus from each healthcare system’s physicians. Any tests, procedures, and [...]

Comments Off on Why Order Sets are a Key Part of the Prescriber Journey

Asembia Sneak Peek: The Cell & Gene Therapy Past, Present, and Future

2022-04-20T19:53:01+00:00April 20th, 2022|Categories: Blog|

  Have you finalized your plans for Asembia yet? As you’re mapping out your schedule, don’t forget to join us for our cell and gene panel presentation on May 4 from 9:30-10:15 AM called “How the Cell & Gene Journey Shifted Over Time — And Where It’s Going Next.” The panel features Kyle Felmet, Vice President, Specialty Commercialization at Two Labs and Cynthia Hwang, Senior Vice President, Government Pricing Programs [...]

Comments Off on Asembia Sneak Peek: The Cell & Gene Therapy Past, Present, and Future

Gearing Up For Asembia

2022-03-16T17:20:12+00:00March 16th, 2022|Categories: Blog|

The Asembia countdown is on and we can hardly wait! There’s nothing quite like Asembia, especially if you’re currently in the weeds of launching your specialty pharmacy product. Whether you’re in need of a new 3PL partner, are hoping to learn about all the possible tech solutions that can support your launch, or are looking for information on what’s driving the specialty pharmacy industry forward, Asembia is for you. What [...]

Comments Off on Gearing Up For Asembia

Patient Services: A Must-have for Any Specialty Product Launch

2022-02-11T18:45:37+00:00February 11th, 2022|Categories: Blog|

Patient Services have become a must-have for any specialty product launching today. Many pharmaceutical clients are looking to expand their reach and offer enhanced services to their patients, particularly in a competitive landscape. So what makes a good program GREAT?  It all starts with identifying needs: Who are my patients? Who are the healthcare providers? Which services may have the greatest impact? [...]

Comments Off on Patient Services: A Must-have for Any Specialty Product Launch

New White Paper: Translating EU Presence to US Market Success

2021-12-06T18:10:39+00:00December 6th, 2021|Categories: Blog|

As the world's largest single pharmaceutical market, the US should – at least at first glance – provide a simplified pathway for companies looking for a stateside translation of their successes in Europe’s patchwork quilt of countries. Unfortunately, that's anything but the case. In this white paper, Howard Miller, CEO of Two Labs, discusses how companies looking to replicate a drug’s EU market success in the US will [...]

Comments Off on New White Paper: Translating EU Presence to US Market Success

What Does Patient Services Support Look Like at Two Labs?

2021-12-04T03:44:51+00:00December 3rd, 2021|Categories: Blog|

There’s an undeniable truth in the pharmaceutical industry: the success of your product relies on the ability of patients, healthcare providers, and caregivers to understand how to access and use it. From reimbursement and financial hurdles to access and adherence challenges, to distribution obstacles, there are a plethora of barriers that manufacturers must devise a strategy to alleviate. And that’s exactly what makes a robust Patient Services strategy [...]

Comments Off on What Does Patient Services Support Look Like at Two Labs?

How to Maximize Pharmacy Availability of Prescription Medicine

2021-10-19T20:42:30+00:00October 19th, 2021|Categories: Blog|

In a world with ever changing needs and demands, especially amongst a global pandemic, issues with the availability of prescription medications continue to challenge the industry. The last words you want to hear as a patient, pharmacist, or sales representative are “out of stock”. The following tips and best practices can help reduce the chances of an issue to begin with: It starts with [...]

Comments Off on How to Maximize Pharmacy Availability of Prescription Medicine

Adding State Licensing to Your Cell and Gene Launch Strategy

2021-07-06T14:21:39+00:00July 16th, 2021|Categories: News|

The main question that sits at the center of the most common licensing questions and obstacles for cell and gene strategies: how do companies license a product that is often never touched by the parties that need to hold the license? Ryan Fields, Sr. Vice President of Regulatory Services at Two Labs answers this question and more in his article featured on Pharmaceutical Outsourcing. Read more here.

Comments Off on Adding State Licensing to Your Cell and Gene Launch Strategy

New White Paper: Healthcare Policy Initiatives – Is Change Coming?

2021-07-13T19:42:14+00:00July 13th, 2021|Categories: Blog|

The high cost of drugs has become a bipartisan discussion among representatives in Washington, DC. Both the Trump and Biden administrations have taken actions to reduce healthcare spending, and particularly have focused on prescription drug spending. In order to better understand these recent policies and their expected impact on US healthcare payers and manufacturers, Two Labs conducted a panel event with Medical Directors and Pharmacy Directors from managed [...]

Comments Off on New White Paper: Healthcare Policy Initiatives – Is Change Coming?

Two Labs, an Envision Pharma Group company Acquires Riparian

2021-07-06T13:52:51+00:00July 7th, 2021|Categories: News|

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting COLUMBUS, Ohio (7/7/2021) -- Two Labs, an industry-leading pharma services company and part of Envision Pharma Group, today announced that it has acquired Riparian, a pharma consulting and SaaS company that helps manufacturers navigate pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs’ suite of pharma services, allowing the [...]

Comments Off on Two Labs, an Envision Pharma Group company Acquires Riparian
Go to Top